Literature DB >> 17056668

Very low-frequency blood pressure variability depends on voltage-gated L-type Ca2+ channels in conscious rats.

Amanda M Langager1, Bailey E Hammerberg, Diane L Rotella, Harald M Stauss.   

Abstract

The mechanisms generating high- frequency (HF) and low-frequency (LF) blood pressure variability (BPV) are reasonably well understood. However, little is known about the origin of very low-frequency (VLF) BPV. We tested the hypothesis that VLF BPV is generated by L-type Ca(2+) channel-dependent mechanisms. In conscious rats, arterial blood pressure was recorded during control conditions (n = 8) and ganglionic blockade (n = 7) while increasing doses (0.01-5.0 mg.100 micro l(-1).h(-1)) of the L-type Ca(2+) channel blocker nifedipine were infused intravenously. VLF (0.02-0.2 Hz), LF (0.2-0.6 Hz), and HF (0.6-3.0 Hz) BPV were assessed by spectral analysis of systolic blood pressure. During control conditions, nifedipine caused dose-dependent declines in VLF and LF BPV, whereas HF BPV was not affected. At the highest dose of nifedipine, VLF BPV was reduced by 86% compared with baseline, indicating that VLF BPV is largely mediated by L-type Ca(2+) channel-dependent mechanisms. VLF BPV appeared to be relatively more dependent on L-type Ca(2+) channels than LF BPV because lower doses of nifedipine were required to significantly reduce VLF BPV than to reduce LF BPV. Ganglionic blockade markedly reduced VLF and LF BPV and abolished the nifedipine-induced dose-dependent declines in VLF and LF BPV, suggesting that VLF and LF BPV require sympathetic activity to be evident. In conclusion, VLF BPV is largely mediated by L-type Ca(2+) channel-dependent mechanisms. We speculate that VLF BPV is generated by myogenic vascular responses to spontaneously occurring perturbations of blood pressure. Other factors, such as sympathetic nervous system activity, may elicit a permissive effect on VLF BPV by increasing vascular myogenic responsiveness.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17056668     DOI: 10.1152/ajpheart.00874.2006

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  12 in total

1.  Low-frequency blood pressure oscillations and inotrope treatment failure in premature infants.

Authors:  Zachary A Vesoulis; Jessica Hao; Christopher McPherson; Nathalie M El Ters; Amit M Mathur
Journal:  J Appl Physiol (1985)       Date:  2017-04-20

2.  Sex- and age-based differences in the effect of central serotonin on arterial blood pressure regulation.

Authors:  Jennifer L Magnusson; Craig A Emter; Kevin J Cummings
Journal:  J Appl Physiol (1985)       Date:  2020-09-10

3.  Blood pressure-renal blood flow relationships in conscious angiotensin II- and phenylephrine-infused rats.

Authors:  Aaron J Polichnowski; Karen A Griffin; Jianrui Long; Geoffrey A Williamson; Anil K Bidani
Journal:  Am J Physiol Renal Physiol       Date:  2013-07-03

4.  Overexpression of SK3 channels dampens uterine contractility to prevent preterm labor in mice.

Authors:  Stephanie L Pierce; Jessica D K Kresowik; Kathryn G Lamping; Sarah K England
Journal:  Biol Reprod       Date:  2008-02-27       Impact factor: 4.285

5.  Effect of nebivolol on beat-to-beat and short-term blood pressure variability in spontaneously hypertensive rats.

Authors:  Facundo Martín Bertera; Julieta Sofía Del Mauro; Ariel Héctor Polizio; Diego Chiappetta; Carlos Alberto Taira; Christian Höcht
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-05-09       Impact factor: 3.000

Review 6.  Cerebral Autoregulation, Brain Injury, and the Transitioning Premature Infant.

Authors:  Zachary A Vesoulis; Amit M Mathur
Journal:  Front Pediatr       Date:  2017-04-03       Impact factor: 3.418

Review 7.  Understanding short-term blood-pressure-variability phenotypes: from concept to clinical practice.

Authors:  Veerendra Melagireppa Chadachan; Min Tun Ye; Jam Chin Tay; Kannan Subramaniam; Sajita Setia
Journal:  Int J Gen Med       Date:  2018-06-22

8.  Nebivolol is more effective than atenolol for blood pressure variability attenuation and target organ damage prevention in L-NAME hypertensive rats.

Authors:  Julieta S Del Mauro; Paula D Prince; Yanina Santander Plantamura; Miguel A Allo; Luciano Parola; Nahuel Fernandez Machulsky; Marcela A Morettón; Eliana P Bin; Germán E González; Facundo M Bertera; Andrea Carranza; Gabriela Berg; Carlos A Taira; Martín Donato; Diego A Chiappetta; Ariel H Polizio; Christian Höcht
Journal:  Hypertens Res       Date:  2021-02-22       Impact factor: 3.872

Review 9.  Arterial pressure and cerebral blood flow variability: friend or foe? A review.

Authors:  Caroline A Rickards; Yu-Chieh Tzeng
Journal:  Front Physiol       Date:  2014-04-07       Impact factor: 4.566

10.  External Counterpulsation Reduces Beat-to-Beat Blood Pressure Variability When Augmenting Blood Pressure and Cerebral Blood Flow in Ischemic Stroke.

Authors:  Ge Tian; Li Xiong; Wenhua Lin; Jinghao Han; Xiangyan Chen; Thomas Wai Hong Leung; Yannie Oi Yan Soo; Lawrence Ka Sing Wong
Journal:  J Clin Neurol       Date:  2016-04-19       Impact factor: 3.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.